INTERNATIONAL MATCHMAKING SYMPOSIUM ADTCA 2024 on 20/21 June

Search for:

Home » _News » Smart Innovations » Page 7

AMR news related to Smart Innovations

For Scientists, Researchers and Innovating Professionals who want to stay adequately informed on Antimicrobial resistance, AMR Insights offers the most comprehensive overview of recently published, global news and information.

Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review

SMART researchers discover unique lysin capable of killing multidrug-resistant bacteria

How pharma economics hold back antibiotic development

Role of mobile genetic elements in the global dissemination of the carbapenem resistance gene blaNDM

Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study

Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections

Discovery of actinomycin L, a new member of the actinomycin family of antibiotics

28 February 2022

Phage therapy in the Covid-19 era: Advantages over antibiotics

28 February 2022

Antibacterial bioactive glass dramatically reduces microbial resistance to antibiotics

21 February 2022

Repurposing of Antibiotics: Sense or Non-sense

19 February 2022

SMART researchers discover unique lysin capable of killing deadly multidrug-resistant bacteria

15 February 2022

Accurate and rapid prediction of tuberculosis drug resistance from genome sequence data using traditional machine learning algorithms and CNN

15 February 2022

The Case for a Subscription Model to Tackle Antimicrobial Resistance

15 February 2022

The State of Innovation in Antibacterial Therapeutics [Report]

12 February 2022

Mini-labs to track and treat superbugs sent to AMR ‘blind spots’

12 February 2022

Machine learning algorithm to characterize antimicrobial resistance associated with the International Space Station surface microbiome

10 February 2022

Indian startup Bugworks Research secures $18M to advance work in AMR

4 February 2022

Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics

4 February 2022

AMR Action Fund head aims to boost innovation, funds for new antibiotics

4 February 2022

Artificial Intelligence and Antibiotic Stewardship

3 February 2022

Impact of Continuous Pharmacist Intervention for Injectable Antimicrobials on the Treatment of Patients with Escherichia coli Bacteremia

3 February 2022

AMR Action Fund Appoints Scientific Advisory Board

1 February 2022

AMR Industry alliance third progress report

30 January 2022

Antibiotic Discovery and Resistance: The Chase and the Race

28 January 2022

Artificial intelligence – the future of antibiotic resistance prevention?

28 January 2022

AMR Action Fund head aims to boost innovation, funds for new antibiotics

28 January 2022

A genome-wide atlas of antibiotic susceptibility targets and pathways to tolerance

24 January 2022

A field test for malaria resistance

14 January 2022

Direct antimicrobial resistance prediction from clinical MALDI-TOF mass spectra using machine learning

13 January 2022

Antimicrobial Resistance and Human Mobility

13 January 2022

Using machine learning to examine drivers of inappropriate outpatient antibiotic prescribing in acute respiratory illnesses

13 January 2022

Researchers discover a new approach to breaking bacterial antibiotic resistance and rescue frontline drug treatments

13 January 2022

New colistin variant outmanoeuvres pathogens

12 January 2022

New: Spotlight on Science by CARB-X

12 January 2022

Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed

12 January 2022

Diagnostics against antimicrobial resistance – the next big move

11 January 2022

Towards a better understanding of antimicrobial resistance dissemination: what can be learnt from studying model conjugative plasmids?

10 January 2022

French Project to Tackle Antibiotic Resistance with Biotech and Economics

French Consortium Pioneers New AMR Development Model

Plasma technology in antimicrobial surface engineering

A Bayesian approach to modeling antimicrobial multidrug resistance

Supercomputers used in arms race with antibiotic resistance

21 December 2021

Promising Innovations To Bend The AMR Curve (Part-I)

21 December 2021

Development and Research Progress of Anti-Drug Resistant Bacteria Drugs

17 December 2021

University of Surrey leads network championing one health innovation

17 December 2021

SPEARHEAD launches to address the silent pandemic of antimicrobial resistance (AMR)

15 December 2021

OpGen subsidiary Ares Genetics announces the strategic expansion of ARESdb proprietary contents

14 December 2021

Modelling within-host evolutionary dynamics of antimicrobial resistance

14 December 2021

U.S. Treasury’s Yellen endorses G7 statement on antibiotics

10 December 2021

A Nonprofit Drug Development Model Is Part of the Antimicrobial Resistance (AMR) Solution

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed